Revel Pharmaceuticals

📍 San Francisco, United States🗓 Founded 2019👥 3 employees
Biotechnology🌐 revelpharmaceuticals.com
Website LinkedIn
Revel Pharmaceuticals is a biotechnology commercializing therapeutic enzymes to degrade age associated molecule damage. We are targeting pathological age associated compounds known as Advanced Glycation End Products (AGEs) which build up on long lived proteins like collagen. AGE accumulation is implicated in multiple diseases of aging, thus Revel Pharmaceuticals is strategically position to develop therapeutics across multiple indications.
0
Total investors
0
Early stage
0
Mid stage
0
Late stage
2019
Founded

Investors

0 investors
All
Early stage
Mid stage
Late stage
No investors in this category
Frequently asked questions
When was Revel Pharmaceuticals founded?
Revel Pharmaceuticals was founded in 2019.
What industry is Revel Pharmaceuticals in?
Revel Pharmaceuticals operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Revel Pharmaceuticals based?
Revel Pharmaceuticals is headquartered in San Francisco, United States.